Mydecine Provides Update on Spin-Out of U.S. Cannabis Assets

MINDCURE Appoints Dr. John Brownstein, the Chief Innovation Officer at Boston...

Tryp Therapeutics Partners with Clinlogix for Clinical Trial Support

The Chopra Foundation and MindMed Enter Into Letter of Intent to...

Cybin Granted IRB Approval for Phase II Clinical Trials of its...

Entheon Biomedical Announces DMT Drug Supply Agreement with Ofichem Group

PT244 – Mark Haberstroh – Mushrooms, Retreat Centers, and Safety

Mydecine Reports First Quarter 2021 Financial Results and Provides Business Update

More than 80% of Americans report one or more symptoms of...

The Impact of Specific Genes on Cannabis Use Disorder

Load more